In the STEP (Semaglutide Treatment Effect in People with Obesity) trials, Semaglutide injection demonstrated significant weight loss compared to placebo in individuals with obesity
Risks and Concerns Quick Answer The main risks of compounded semaglutide stem from the absence of FDA oversight: quality may vary between pharmacies, ingredient consistency is not federally guaranteed, and there is potential for contamination or inaccurate dosing
J Invest Dermatol
"The healthcare professional who is responsible for providing the prescription should take all of these factors into consideration when presenting medication options," he adds The bottom line Both phentermine and Wegovy can be useful weight-loss medications, but it's helpful to keep in mind that they work in different ways and are taken for different time periods
Chapman CD, Frey WH 2nd, Craft S, Danielyan L, Hallschmid M, Schith HB, et al
Seplveda, N., Stresman, G., White, M